Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James W Dear

Showing results (21-30 of 140) with videos related to

Pageof 14
Sort By:
British Journal of Clinical Pharmacology|August 29, 2006
Are rare diseases still orphans or happily adopted? The challenges of developing and using orphan medicinal productsJames W Dear, Pajaree Lilitkarntakul, David J Webb
BMJ (Clinical Research Ed.)|November 16, 2023
Paracetamol use in adultsThomas M Caparrotta, Emma Carduff, James W Dear
BMJ (Clinical Research Ed.)|April 22, 2011
Management of paracetamol poisoningRobin E Ferner, James W Dear, D Nicholas Bateman
The New England Journal of Medicine|November 4, 2008
Acetaminophen poisoningJames W Dear, W Stephen Waring, D Nicholas Bateman
British Journal of Clinical Pharmacology|November 14, 2012
A systematic review of the effect of paracetamol on blood pressure in hypertensive and non-hypertensive subjectsEmma J Turtle, James W Dear, David J Webb
Heart (British Cardiac Society)|November 16, 2007
New guidelines for drive-by renal arteriography may lead to an unjustifiable increase in percutaneous interventionJames W Dear, Paul L Padfield, David J Webb
BMJ Clinical Evidence|October 20, 2015
Paracetamol (acetaminophen) poisoningB Kevin Park, James W Dear, Daniel J Antoine
European Journal of Clinical Pharmacology|October 26, 2017
Are some people at increased risk of paracetamol-induced liver injury? A critical review of the literatureThomas M Caparrotta, Daniel J Antoine, James W Dear
BMJ (Clinical Research Ed.)|July 12, 2015
Where are we now with paracetamol?James W Dear, Daniel J Antoine, B Kevin Park
Expert Opinion on Drug Safety|March 1, 2016
Recent advances in biomarkers and therapeutic interventions for hepatic drug safety - false dawn or new horizon?Joanna I Clarke, James W Dear, Daniel J Antoine
Pageof 14

Showing results (21-30 of 140) with videos related to

Sort By:
Pageof 14
British Journal of Clinical Pharmacology|August 29, 2006
Are rare diseases still orphans or happily adopted? The challenges of developing and using orphan medicinal productsJames W Dear, Pajaree Lilitkarntakul, David J Webb
BMJ (Clinical Research Ed.)|November 16, 2023
Paracetamol use in adultsThomas M Caparrotta, Emma Carduff, James W Dear
BMJ (Clinical Research Ed.)|April 22, 2011
Management of paracetamol poisoningRobin E Ferner, James W Dear, D Nicholas Bateman
The New England Journal of Medicine|November 4, 2008
Acetaminophen poisoningJames W Dear, W Stephen Waring, D Nicholas Bateman
British Journal of Clinical Pharmacology|November 14, 2012
A systematic review of the effect of paracetamol on blood pressure in hypertensive and non-hypertensive subjectsEmma J Turtle, James W Dear, David J Webb
Heart (British Cardiac Society)|November 16, 2007
New guidelines for drive-by renal arteriography may lead to an unjustifiable increase in percutaneous interventionJames W Dear, Paul L Padfield, David J Webb
BMJ Clinical Evidence|October 20, 2015
Paracetamol (acetaminophen) poisoningB Kevin Park, James W Dear, Daniel J Antoine
European Journal of Clinical Pharmacology|October 26, 2017
Are some people at increased risk of paracetamol-induced liver injury? A critical review of the literatureThomas M Caparrotta, Daniel J Antoine, James W Dear
BMJ (Clinical Research Ed.)|July 12, 2015
Where are we now with paracetamol?James W Dear, Daniel J Antoine, B Kevin Park
Expert Opinion on Drug Safety|March 1, 2016
Recent advances in biomarkers and therapeutic interventions for hepatic drug safety - false dawn or new horizon?Joanna I Clarke, James W Dear, Daniel J Antoine
Pageof 14